Скачать или смотреть Morris Tech Meetup #71: COVID Tech with Pavita Howe of Rutgers (first COVID-19 saliva test)

We are excited to have Pavita Howe join us to discuss COVID-19 innovation at Rutgers. Pavita has been on special assignment to support the Rutgers RUCDR Infinite Biologics team in the deployment of the COVID-19 saliva test, which was the first COVID-19 saliva test to receive Emergency Use Authorization (EUA) by the FDA during the coronavirus pandemic. In June 2020, Rutgers announced the spinout of the RUCDR Infinite Biologics lab to create a new company, Infinity BiologiX, via a $44 million Asset Purchase Agreement. The new company will operate independently of Rutgers but will still be affiliated with the university.

Pavita will speak about Rutgers' success in developing the Coronavirus saliva test and ongoing efforts to commercialize it. She will also speak about other non-Covid entrepreneurial activities at Rutgers.

Also, thank you to our Tech Startup presenter, Ryan Herd of Caregiver Smart Solutions.